Current NDC auxiliary source row compounder:3975

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 69852-307
Product Ndc: 69852-307
Product Ndc Digits: 69852307
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Lidocaine/Tetracaine
Proprietary Name Suffix: [empty]
Nonproprietary Name: Lidocaine/Tetracaine
Dosage Form Name: OINTMENT
Route Name: TOPICAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Eagle Pharma Outsourcing, LLC
Establishment Name: Eagle Pharma Outsourcing, LLC
Establishment Fei: [empty]
Substance Name: LIDOCAINE; TETRACAINE
Active Ingredients Info: 10.35 g/45 g; 3.15 g/45 g
History Active Ingredients Raw: LIDOCAINE; TETRACAINE
History Active Ingredients Info Raw: 10.35 g/45 g; 3.15 g/45 g
History Dosage Raw: OINTMENT
Dea Schedule: [empty]
Package Ndc Raw: 69852-307-45
Package Ndc: 69852-307-45
Package Ndc Digits: 6985230745
Package Ndc11: 69852030745
Package Description: 13.5 g in 1 BOTTLE, PUMP (69852-307-45)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:3975
Source Row Number: 3975
Source Row Hash: 852c25c9cd9f1d94a22c5c99304c36647ddf3a2ac0f669474bc917d812ce2695
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27

Exact raw FDA source fields#

{
    "ROUTENAME": "TOPICAL",
    "PRODUCTNDC": "69852-307",
    "DEASCHEDULE": "",
    "LABELERNAME": "Eagle Pharma Outsourcing, LLC",
    "SUBSTANCENAME": "LIDOCAINE; TETRACAINE",
    "DOSAGEFORMNAME": "OINTMENT",
    "NDCPACKAGECODE": "69852-307-45",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Lidocaine/Tetracaine",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Lidocaine/Tetracaine",
    "PACKAGEDESCRIPTION": "13.5 g in 1 BOTTLE, PUMP (69852-307-45) ",
    "ACTIVEINGREDIENTSINFO": "10.35 g/45 g; 3.15 g/45 g",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:3975
Source Row Number: 3975
Status Scope: package
Lookup Ndc: 69852-307-45
Lookup Ndc Digits: 6985230745
Product Ndc: 69852-307
Product Ndc Digits: 69852307
Package Ndc: 69852-307-45
Package Ndc Digits: 6985230745
Package Ndc11: 69852030745
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 852c25c9cd9f1d94a22c5c99304c36647ddf3a2ac0f669474bc917d812ce2695
Import Run Id: 20261025T224840Z
Loaded At: 2026-10-25 22:53:27